TAM-derived CCL18 induces EMT in breast cancer and activates ERK and Akt/GSK-3β/Snail signaling in human umbilical vein endothelial cells, thereby contributing to its pro-angiogenic effect [118]. The gene discussed is CCL18; the disease is breast carcinoma.